Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.

MLA

Ditters, Imke A. M., et al. “Home-Based Infusion of Alglucosidase Alfa Can Safely Be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 37, no. 5, Sept. 2023, pp. 685–98. EBSCOhost, https://doi.org/10.1007/s40259-023-00609-2.

APA

Ditters, I. A. M., van Kooten, H. A., van der Beek, N. A. M. E., Hardon, J. F., Ismailova, G., Brusse, E., Kruijshaar, M. E., van der Ploeg, A. T., van den Hout, J. M. P., & Huidekoper, H. H. (2023). Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 37(5), 685–698. https://doi.org/10.1007/s40259-023-00609-2

Chicago

Ditters, Imke A M, Harmke A van Kooten, Nadine A M E van der Beek, Jacqueline F Hardon, Gamida Ismailova, Esther Brusse, Michelle E Kruijshaar, Ans T van der Ploeg, Johanna M P van den Hout, and Hidde H Huidekoper. 2023. “Home-Based Infusion of Alglucosidase Alfa Can Safely Be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.” BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 37 (5): 685–98. doi:10.1007/s40259-023-00609-2.